June 19, 2014
Ono Pharmaceutical said on June 17 that it has agreed with German partner Merck KGaA to terminate their licensing deal for ONO-4641, an investigational multiple sclerosis (MS) drug discovered by the Japanese drug maker. Merck acquired the worldwide exclusive rights...read more